CLINICAL PROFILES
Author:
Open Access
- 1 October 1968
- journal article
- Published by American Society of Hematology in Blood
- Vol. 32 (4) , 690-695
Abstract
Experience by many observers in the last few years has shown that intravenously administered iron dextran is a useful and safe agent in the management of iron-deficiency anemia. The conscientious physician, who has diagnosed iron deficiency by the absence of hemosiderin in marrow or by the characteristic serum values for iron and total iron-binding capacity, may well prefer to inject the calculated correct amount of iron rather than depend on the capriciousness of the patient’s gastrointestinal tract or pill-taking habits. In clinical situations in which the doctor-patient contacts are severely limited in number, intravenous injection may be the only reliable way to administer the proper amount of iron. Treatment by intravenous injection, only after employing firm diagnostic criteria, may restore iron to its proper place in the physician’s armamentarium and elevate it from buckshot to bullet.Keywords
This publication has 6 references indexed in Scilit:
- Total dose intravenous infusion of iron-dextran (Imferon) in severe anemiaAmerican Journal of Obstetrics and Gynecology, 1966
- ADMINISTRATION OF IRON DEXTRAN COMPLEX BY CONTINUOUS INTRAVENOUS INFUSIONBJOG: An International Journal of Obstetrics & Gynaecology, 1965
- Reactions to Intravenous Iron DextranBMJ, 1965
- PARENTERAL IRON THERAPY IN PREGNANCYBJOG: An International Journal of Obstetrics & Gynaecology, 1965
- Reactions to Total Dose Intravenous Infusion of Iron Dextran (Imferon)BMJ, 1965
- TREATMENT OF 300 CASES OF IRON DEFICIENCY OF PREGNANCY BY TOTAL DOSE INFUSION OF IRON‐DEXTRAN COMPLEXBJOG: An International Journal of Obstetrics & Gynaecology, 1964